Poster 3
- Jul 2, 2023
- 1 min read
Complete Scalp Hair Regrowth and Predictors of Response in Patients with Alopecia Areata Receiving Ritlecitinib 50 mg up to 3 Years in the ALLEGRO Clinical Trial Program
Brett King, Rodney Sinclair, Lidia Rudnicka, Sergio Vañó-Galvan, Bianca Maria Piraccini, Manabu Ohyama, Wenyu Wu, Gianluca Bonfanti, Roger A Edwards, Robert Wolk, Stephen Goodrich, Dalia Wajsbrot, Helen Tran, Alexandre Lejeune


